AllBio provides services in the areas of gene sequencing, precision medicine, protein expression, and customized antibodies. We service both the academic research and medical communities and continue to develop new applications and technologies through our R&D division. Currently our main focus is to develop a protein transistor based detection platform for drug discovery and small molecule and protein-drug interactions (pharmacokinetics). When faced with the increasingly challenging research environment and the shortage of research resources, AllBio seeks to leverage innovative technologies from both basic and clinical research to help advance Taiwan's medical and health industries to the age of big data and digital health.